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Introduction Disease Process/Signs and Symptoms References 
     The beginning stage in the 
development of Lyme disease is most 
recognized as the localized rash called 
erythema migrans. It is also commonly 
called “bull’s eye rash” due to its 
physical appearance. The rash forms 
after about 3-30 days after the tick bite 
and is around 5 cm in diameter but may 
spread up to around 30 cm (Pearson, 
2015). This early phase of the infection 
is the easiest time to diagnose the 
disease when erythema migrans is 
present. It is the classic symptom of 
Lyme disease but fades as the individual 
progresses to the further stages of 
infection. Erythema migrans is usually 
not irritating or painful and can many 
times go unnoticed without the presence 
of any systemic involvement, presenting 
as flu like symptoms (Pearson, 2015). 
     Early dissemination of Lyme disease 
accompanies symptoms of fever, 
headache, musculoskeletal pain, and 
general malaise. Secondary lesions of 
erythema migrans may also be present 
(Pearson, 2015). Many other body 
systems begin to be affected as Borrelia 
burgdorferi migrates throughout the 
tissues.  
 
     Lyme disease is the most common 
vector borne illness found in the United 
States. Each year 30,000 people are 
diagnosed with the disease, with many 
more cases going unreported (Centers 
for Disease Control and Prevention, 
2015). The vector responsible for 
spreading the disease is the deer tick. The 
infection itself is caused by the spirochete 
Borrelia burgdorferi. This bacteria is 
transmitted through the saliva from the 
bite of a deer tick. Diagnosis can be 
challenging due to the fact that multiple 
systems of the body can be affected with 
different severities. Early diagnosis and 
treatment is critical in the prevention of 
progressive and chronic illness.  
     Lyme disease is a relevant issue of 
rural Northeast Ohio. The prevalence of 
the disease is not as common as the high 
risk areas in the New England states. 
However, deer ticks can easily be found 
in any woods close to home. This disease 
requires more awareness and research 
within the healthcare community. The 
pathology of the disease is understood, 
but details of exactly how Borrelia 
burgdorferi affects certain areas of the 
body such as the nervous system remains 
unclear (Halperin, 2014). More 
importantly physicians and advanced 
practice nurses in this area need 
educated on signs and symptoms of the 
disease so a timely diagnosis can be 
made. Treatment is simple and 
complications are preventable with early 
diagnosis. Borrelia burgdorferi has been 
extensively researched, but more 
information is needed to fully 
understand how this bacteria has 
mastered the ability to evade human 
immunity (Kenedy, Lenhart, & Akins, 
2012). 
 
       Joint and muscles are commonly 
affected causing pain with or without 
inflammation of the joint. Neurological 
symptoms present with Bell's palsy like 
paralysis of the cranial nerves and 
radicular neuropathies leading to other 
peripheral manifestations. 
Cardiovascular symptoms are not as 
common but can lead to varying degrees 
of heart block (Bratton et al., 2008).  
            Late dissemination of Lyme disease 
involves chronic relapsing and remitting 
symptoms of the bodily system affected 
by the bacteria. Peripheral, central and 
autonomic nervous systems can be 
chronically affected in some of the 
population with Lyme disease (Pearson, 
2015). This includes a vast and complex 
presentation of symptoms making 
diagnosis even more difficult once it has 
reached the later stages. Pearson (2015) 
describes these symptoms as 
encephalopathy, headache, mood 
changes, peripheral neuropathy, and 
even blood pressure changes (p. 89). 
Collagen rich tissues are usually the site 
of chronic disease including the eyes, 
nerve tissues and joints causing many 
sensory and motor deficits (Pearson, 
2015). 
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Conclusion 
The underlying pathophysiology of Lyme disease begins in the white footed mouse 
acting as the reservoir for B. burgdorferi and the deer tick acting as the vector to spread 
the bacteria to humans. The tick usually feeds for one to two days, transmitting the bacteria 
through its saliva (Bratton et al., 2008). The initial infection identified as erythema migrans 
is a localized immune response that takes place in the skin. B. burgdorferi disseminates to 
other organs of the body in about two weeks. The outer surface protein of the bacteria 
quickly triggers chemokines that attract B cells which then produce antibodies specific to 
the B. burgdorferi. (Halperin, 2014). The inflammatory symptoms are a humoral and 
cellular immune response to the outer surface protein which is then believed to trigger an 
auto immune response (Steere, Drouin, & Glickstein, 2015). 
     The exact microbiology of the disease is still controversial due to the fact that it is very 
hard to find evidence of bacterial presence in samples thought to be infected with the 
spirochete. It is hard to imagine that such a small presence of the pathogen is able to create 
such a strong immune reaction (Halperin, 2015). Chronic joint inflammation along with 
neurological deficits can persist even when no bacteria is detected after treatment with 
antibiotics (Steere et al, 2011). 
     One thing that is certain is that B burgdorferi has become proficient at evading  
immunity through antigenetic variations of the outer surface protein and having the ability 
to bind to human tissues (Kenedy et al., 2012). This may describe how the human immune 
system becomes sensitive to self tissues through molecular mimicry eventually attacking 
its own cells. Once systemic Lyme disease has developed, antibiotics become less effective 
and chronic remitting symptoms last throughout the lifetime. 
 
Underlying pathophysiology 
      
     The severity of the disease is based entirely on how quickly Lyme disease is recognized 
and treated along with where the bacteria have colonized in the body. Not everyone 
presents with the same symptoms since the B. burgdorferi bacteria has the ability to 
invade such a variety of tissues and organs throughout the body. The symptoms tend to 
vary even more as the disease progresses. For example, one patient may present with 
complaints of peripheral neuropathy and joint pain while another may only complain of 
muscle pain. It would appear as if the two cases are completely unrelated when in fact 
they are both infected with the same pathogen. The only symptom that remains consistent 
between cases is the early sign of the erythema migrans rash (Pearson, 2015). 
     The difficulty to diagnose this disease has led to the estimate that as many as one 
million people are infected each year. This is much higher than the CDC’s report of around 
30,000 cases annually. The cause of the under diagnosing is the vague and subjective 
symptoms that present late in the disease along with the strict diagnostic guidelines to 
make it definitive for Lyme disease (Stricker & Johnson, 2014). Another source claims 
similar predictions of the true number of new cases, ranking it seventh in infectious 
diseases in the United States. The same study also reported the financial burden and 
healthcare resources needed to manage the chronic condition. Research showed that 
healthcare costs for those with Lyme disease is almost $3,000 more a year with 87% more 
outpatient visits compared to the control group (Adrion, Aucott, & Weiner, 2014). This is a 
clear indication of the debilitating effects of Lyme disease when it has progressed to the 
later stages 
     The most important aspect of care is early treatment of the disease, 
but first the diagnosis must be made. Diagnosis can be made one of two 
ways, usually in a two step combination of the tests. These tests are the 
enzyme-linked immunosorbent assay, commonly called ELISA, and the 
Western blot test. The presentation of erythema migrans rash along with 
patient history of outdoors and exposure to ticks should indicate the 
presence of infection. Treatment should begin even before the lab results 
confirm diagnosis (Kowalski, Tata, Berth, Mathiason, & Agger, 2010). As 
stated earlier, it is difficult to make a diagnosis in the later stages of 
disease since the healthcare provider only has subjective symptoms that 
mimic other diseases. This is why it is important to conduct a thorough 
history including knowledge of geographical hotspots for prevalence of 
Lyme disease.  
     The early stage of Lyme disease is easily treated and with a good 
prognosis. This is when first symptoms of fever and erythema migrans 
rash are present. The two common antibiotics used to fight the infection 
is a ten to twenty day treatment of doxycycline or amoxicillin. Research 
has shown that the exact duration even with treatment less than ten days 
has no effect on outcome (Kowalski et al., 2010).   
Late stages of infection are more often difficult to cure. There is no 
standard treatment for disseminated Lyme disease. Both IV and oral 
antibiotics are used with controversy that usually point to the ineffective 
results. Symptoms can be managed with anti-inflammatories, and other 
treatments based on which bodily system is involved. Unfortunately, 
there is still much unknown about the actions of the B. burgdorferi in the 
late stages, so there is no set standard of care in the chronic form 
(Halperin, 2014). 
     Another important topic to discuss is prevention measures and to 
educate the patient on signs and symptoms of the disease. This is 
especially important in areas such as the New England States where the 
disease is most prevalent. However, it is not limited to those states and 
can be found anywhere the deer tick can survive. People who are 
outdoor enthusiasts such as hikers and hunters are at greater risk for 
Lyme disease and need to be reminded to check their skin for ticks. 
Insect repellant and protective clothing can offer an effective barrier 
against ticks getting to the skin. Finally, providing education on common 
signs and symptoms of disease such as fever and erythema migrans is 
important so these conditions are not overlooked (Harvard Medical 
School, 2014). 
 
Significance of Pathophysiology 
Lyme disease is a mysterious illness that continues to outsmart 
those in the medical profession due to its ability to evade human 
immunity. There is much more research and clinical trials needed to 
effectively combat or even manage the symptoms of disease once it 
reaches the chronic form. Lyme disease often goes undetected in the early 
stages and therefore gets under diagnosed. It can be difficult to diagnose 
when the symptoms mimic other diseases and affect many different 
organs of the body.  That is why it is so important that healthcare 
providers are up to date with their knowledge so a diagnosis can be made 
with immediate treatment. If left untreated, the physical, financial, and 
emotional toll can last a lifetime. 
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Right: Deer tick 
commonly found in North 
America. Copyright 2013 
by My Times 
Right: Areas of the United 
States at highest risk for 
Lyme disease. Copyright 2013 
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Left: Erythema Migrans 
rash after a tick bite. 
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